Recombinant Human CPP Protein，His

The research on CPP (Cell-Penetrating Peptides) recombinant proteins has gained significant attention in recent years due to their potential to facilitate the delivery of a variety of therapeutic agents, including peptides, proteins, and nucleic acids, across biological membranes. CPPs are short sequences of amino acids that can penetrate cell membranes, enabling the transport of cargo molecules directly into cells without the need for invasive techniques. The growing interest in CPPs is driven by the increasing demand for innovative drug delivery systems that can enhance the efficacy of treatments while reducing side effects. Advances in molecular biology and protein engineering have enabled researchers to develop CPPs with improved specificity, efficiency, and stability. Additionally, the ability to fuse CPPs with recombinant proteins allows for targeted delivery, thereby enhancing therapeutic outcomes for diseases such as cancer, genetic disorders, and viral infections. As a result, CPPs have emerged as a promising tool in the fields of biotechnology and medicine, paving the way for novel approaches to drug development and therapeutic intervention. Ongoing studies are focused on elucidating the mechanisms underlying CPP-mediated cellular uptake, optimizing their design for specific applications, and exploring their potential in various medical fields, making CPPs a vibrant area of investigation in contemporary biomedical research.